Management of severe hypertension in pregnancy

Seminars in Perinatology

Volumn 40, Issue 2, 2016, Pages 112-118

  Moroz, Leslie A ^a   Simpson, Lynn L ^a   Rochelson, Burton ^b  

^a Department of Medicine   (United States)

^b Northwell Health   (United States)

Author keywords

Antihypertensive therapy; Postpartum hypertension; Preeclapsia; Severe hypertension

Indexed keywords

HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; NIFEDIPINE; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT;

ASTHMA; BRAIN DISEASE; CONFUSION; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE SEVERITY; ECLAMPSIA; FEMALE; GESTATIONAL AGE; HEADACHE; HEART FAILURE; HEART RATE; HUMAN; KIDNEY FAILURE; LETHARGY; LIVER DYSFUNCTION; LUNG EDEMA; MATERNAL HYPERTENSION; MEDICAL DOCUMENTATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT EDUCATION; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SEIZURE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; VISUAL DISORDER; ALGORITHM; CLINICAL DECISION MAKING; DECISION SUPPORT SYSTEM; EPIDEMIOLOGY; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL MORTALITY; MORTALITY; PREGNANCY; PRENATAL CARE; PROCEDURES; SEVERITY OF ILLNESS INDEX; STANDARDS; UNITED STATES;

ALGORITHMS; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; CLINICAL DECISION-MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MAGNESIUM SULFATE; MATERNAL MORTALITY; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL CARE; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84960127695     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2015.11.017     Document Type: Review

References (21)

1. Clark S.L., Belfort M.A., Dildy G.A., Herbst M.A., Meyers J.A., Hankins G.D. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008, 199(1). 36e31-36e3135.
2. The California pregnancy-associated mortality review. Report from 2002 and 2003 Maternal Death Reviews. California Department of Public Health, Maternal Child and Adolescent Health Division. Sacramento; 2011.
3. Knight M., Kenyon S., Brocklehurst P., Neilson J., Shakespeare J., Kurinczuk J.J. Saving Lives, Improving Mothers' Care-Lessons Learned to Inform Future Maternity Care From the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-12 2014, National Perinatal Epidemiology Unit, University of Oxford, Oxford.
4. National Institute for Health and Care Excellence. CG107: Hypertension in pregnancy. From: ; August 2010, modified January 2011. http://www.nice.org.uk/guidance/CG107.
5. Singh S., McGlennan A., Englank A., Simons R. A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS). Anaesthesia 2012, 67(1):12-18.
6. D'Alton M.E., Main E.K., Menard M.K., Levy B.S. The national partnership for maternal safety. Obstet Gynecol 2014, 123(5):973-977.
7. ACOG District II Executive Summary: Safe Motherhood Initiative. Accessed 05.05.15. http://www.acog.org/About-ACOG/ACOG-Districts/District-II/SMI-Project-Overview.
8. Zuleta-Tobon J.J., Pandales-Perez H., Sanchez S., Velez-Alvarez G.A., Velasquez-Penagos J.A. Errors in the treatment of hypertensive disorders of pregnancy and their impact on maternal mortality. Int J Gynecol Obstet 2013, 121(1):78-81.
9. American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013, 122(5):1122-1131.
10. Committee on Obstetric Practice Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Committee Opinion No. 623. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015, 125(2):521-525.
11. Lindenstrom E., Boysen G., Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am J Epidemiol 1995, 142(2):1279-1290.
12. Martin J.N., Thigpen B.D., Moore R.C., Rose C.H., Cushman J., May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005, 105(2):246-254.
13. Heida K.Y., Zeeman G.G., Van Veen T.R., Hulzebos C.V. Neonatal side effects of maternal labetalol treatment in severe preeclampsia. Early Hum Dev 2012, 88(7):503-507.
14. Pickles C.J., Symonds E.M., Pipkin-Broughton F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989, 96(1):38-43.
15. Vigil-De Gracia P., Lasso M., Ruiz E., Vega-Malek J.C., de Mena F.T., Lopez J.C. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2006, 128(1-2):157-162.
16. Magee L.A., Miremadi S., Li J., Cheng C., Ensom M.H., Carleton B., Cote A.M., von Dadelszen P. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005, 193(1):153-163.
17. Pope J.E., Anderson J.J., Felson D.T. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993, 153:477-484.
18. Snowden S., Nelson R. The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients. Cardiol Rev 2011, 19(4):184-191.
19. Clark S.L., Belfort M.A., Dildy G.A., et al. Emergency department use during the postpartum period: implication for current management of the puerperium. Am J Obstet Gynecol 2010, 203(38):e1-e6.
20. Khan K.S., Wojdyla D., Say L., Gülmezoglu A.M., Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-1074.
21. Kassebaum N.J., Bertozzi-Villa A., Coggeshall M.S., et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384(9947):980-1004.